#ctcs arama sonuçları

CTCS provides respectful personal care services across the UK, supporting hygiene, comfort and dignity at home. Contact us: 📲0116 509 3300 📩[email protected] #PersonalCareUK #DignifiedCare #CTCS

ctcscare's tweet image. CTCS provides respectful personal care services across the UK, supporting hygiene, comfort and dignity at home.
Contact us:
📲0116 509 3300
📩adultcare@cometogether-cs.co.uk
#PersonalCareUK #DignifiedCare #CTCS

Recent advances in droplet-based microfluidics in liquid biopsy for cancer diagnosis. Strengths, drawbacks, challenges and future perspectives. #CTCs #ctDNA #miRNA Circulating tumor #exosomes 🔻 doi.org/10.1002/dro2.92

CrozrX's tweet image. Recent advances in droplet-based microfluidics in liquid biopsy for cancer diagnosis. Strengths, drawbacks, challenges and future perspectives.
#CTCs #ctDNA #miRNA Circulating tumor #exosomes
🔻
doi.org/10.1002/dro2.92
CrozrX's tweet image. Recent advances in droplet-based microfluidics in liquid biopsy for cancer diagnosis. Strengths, drawbacks, challenges and future perspectives.
#CTCs #ctDNA #miRNA Circulating tumor #exosomes
🔻
doi.org/10.1002/dro2.92
CrozrX's tweet image. Recent advances in droplet-based microfluidics in liquid biopsy for cancer diagnosis. Strengths, drawbacks, challenges and future perspectives.
#CTCs #ctDNA #miRNA Circulating tumor #exosomes
🔻
doi.org/10.1002/dro2.92
CrozrX's tweet image. Recent advances in droplet-based microfluidics in liquid biopsy for cancer diagnosis. Strengths, drawbacks, challenges and future perspectives.
#CTCs #ctDNA #miRNA Circulating tumor #exosomes
🔻
doi.org/10.1002/dro2.92

Key 🔑 for growing organoids from⬅️🟣🔵🔴#CTCs is picking the: ✔️right time ✔️right biology ✔️right platform ✔️efficient communication ✔️timely processing ✅great team 🤝🙌🏽 @ReduzziCarol @CtcLaboratory #ColorectalCancer #CRCSM #BCSM #ISLB24 @isliquidbiopsy #LiquidBiopsies

pashtoonkasi's tweet image. Key 🔑 for 
growing organoids from⬅️🟣🔵🔴#CTCs is picking the:
✔️right time
✔️right biology
✔️right platform
✔️efficient communication
✔️timely processing
✅great team 🤝🙌🏽

@ReduzziCarol @CtcLaboratory 

#ColorectalCancer #CRCSM #BCSM 
 #ISLB24 @isliquidbiopsy #LiquidBiopsies

MicroOrganoSphere (MOS): A new approach for growing circulating tumor cell (CTC)-derived organoids. Promising results in BC & CRC samples, though challenges in growth phase remain. 🩸 Unlocking CTC potential for precision oncology! #LiquidBiopsy #Oncology #ISLB24

DrYukselUrun's tweet image. MicroOrganoSphere (MOS): A new approach for growing circulating tumor cell (CTC)-derived organoids. Promising results in BC & CRC samples, though challenges in growth phase remain.

🩸 Unlocking CTC potential for precision oncology!

#LiquidBiopsy #Oncology #ISLB24


🎤 Hear it from our speakers! On March 17, 2025, at 14:00, @ReduzziCarol will take the stage at FOCUS on TOP in the #LiquidBiopsy Session, exploring the role of circulating tumor cells (#CTCs) in #MRD monitoring with #ctDNA. Program and registration: 👇 ecm.meetingsrl.eu/focus_TOP25/de…

LiquidBioGroup's tweet image. 🎤 Hear it from our speakers!

On March 17, 2025, at 14:00, @ReduzziCarol will take the stage at FOCUS on TOP in the #LiquidBiopsy Session, exploring the role of circulating tumor cells (#CTCs) in #MRD monitoring with #ctDNA.

Program and registration: 👇
ecm.meetingsrl.eu/focus_TOP25/de…

Delighted to have contributed to this book📕on Transplant Oncology. Edited by: @MaenAbdelrahim Foreword: @JimAllisonPhD 📝My chapter focuses on #LiquidBiopsies #CTCs, 🟣🟠 #ctDNA🩸🧬and beyond💡. Out now➡️Amazon/Elsevier. 📌a.co/d/bOQu50R @OncoAlert @DrawImpacts

pashtoonkasi's tweet image. Delighted to have contributed to this book📕on Transplant Oncology. 

Edited by: @MaenAbdelrahim
Foreword: @JimAllisonPhD

📝My chapter focuses on #LiquidBiopsies #CTCs, 🟣🟠 #ctDNA🩸🧬and beyond💡.

Out now➡️Amazon/Elsevier. 
📌a.co/d/bOQu50R

@OncoAlert @DrawImpacts
pashtoonkasi's tweet image. Delighted to have contributed to this book📕on Transplant Oncology. 

Edited by: @MaenAbdelrahim
Foreword: @JimAllisonPhD

📝My chapter focuses on #LiquidBiopsies #CTCs, 🟣🟠 #ctDNA🩸🧬and beyond💡.

Out now➡️Amazon/Elsevier. 
📌a.co/d/bOQu50R

@OncoAlert @DrawImpacts
pashtoonkasi's tweet image. Delighted to have contributed to this book📕on Transplant Oncology. 

Edited by: @MaenAbdelrahim
Foreword: @JimAllisonPhD

📝My chapter focuses on #LiquidBiopsies #CTCs, 🟣🟠 #ctDNA🩸🧬and beyond💡.

Out now➡️Amazon/Elsevier. 
📌a.co/d/bOQu50R

@OncoAlert @DrawImpacts

Timely #AACR24 with the 1st approval of an agnostic ADC for HER2-positive cancers. ?debate on criteria. My 2 cents: the true HER2➕➕➕ are hard to miss🔬. 💡➕it’ll be corroborated by ERBB2 🧬 amplification on other tests #ctDNA #CTCs. Approval🔑➡️access.👇🏾is HCC. @OncoAlert

pashtoonkasi's tweet image. Timely #AACR24 with the 1st approval of an agnostic ADC for HER2-positive cancers.

?debate on criteria.

My 2 cents: the true HER2➕➕➕ are hard to miss🔬.

💡➕it’ll be corroborated by ERBB2 🧬 amplification on other tests #ctDNA #CTCs.

Approval🔑➡️access.👇🏾is HCC. @OncoAlert

✅N-of-1 Precision Medicine: this story is very dear to my heart. Liquid biopsies➡️saving lives. We stumbled on HER2 in refractory liver cancer (HCC not cholangiocarcinoma). #CTCs🔴🟠🟡 not just #ctDNA🧬. AFP>200,000📉900 now. @OncoAlert Free Full text: sciencedirect.com/science/articl…

pashtoonkasi's tweet image. ✅N-of-1 Precision Medicine: this story is very dear to my heart.

Liquid biopsies➡️saving lives.
We stumbled on HER2 in refractory liver cancer (HCC not cholangiocarcinoma).

#CTCs🔴🟠🟡 not just #ctDNA🧬.
AFP>200,000📉900 now.

@OncoAlert
Free Full text: sciencedirect.com/science/articl…


Liquid biopsy plenary from Dr. @AlixPanabieres at #Targets23. A global leader in #CTCs - shows what we can learn about drug resistance from CTC clones, such as her a eminal work on culturing CTCs. More complexity than ctDNA. Ready for more interventional studies in this space!

StephenVLiu's tweet image. Liquid biopsy plenary from Dr. @AlixPanabieres at #Targets23. A global leader in #CTCs - shows what we can learn about drug resistance from CTC clones, such as her a eminal work on culturing CTCs. More complexity than ctDNA. Ready for more interventional studies in this space!

Mesenchymal (vimentin+) circulating tumor cells (#CTCs) may be progostic for progression in ALK+ #NSCLC. Great to see more non-invasive tests for progression. Collaboration between @NagrathSunitha Dr. Yuru Chen & Dr. Angel Qin @UMRogelCancer #AACR25 @ALKPositiveinc

LUNGevity's tweet image. Mesenchymal (vimentin+) circulating tumor cells (#CTCs) may be progostic for progression in ALK+ #NSCLC. Great to see more non-invasive tests for progression. Collaboration between @NagrathSunitha Dr. Yuru Chen & Dr. Angel Qin @UMRogelCancer #AACR25 @ALKPositiveinc
LUNGevity's tweet image. Mesenchymal (vimentin+) circulating tumor cells (#CTCs) may be progostic for progression in ALK+ #NSCLC. Great to see more non-invasive tests for progression. Collaboration between @NagrathSunitha Dr. Yuru Chen & Dr. Angel Qin @UMRogelCancer #AACR25 @ALKPositiveinc
LUNGevity's tweet image. Mesenchymal (vimentin+) circulating tumor cells (#CTCs) may be progostic for progression in ALK+ #NSCLC. Great to see more non-invasive tests for progression. Collaboration between @NagrathSunitha Dr. Yuru Chen & Dr. Angel Qin @UMRogelCancer #AACR25 @ALKPositiveinc

Who else is uploading their slides & posters for @ASCO #GI23? Always the final hours.🙃 #ctDNA #CTCs #LiquidBiopsies #PrecisionMedicine #PrecisionOncology #CRCSM #HPBCSM #ESOCSM #STCSM #PANCSM


Congrats to our @CluB_Cancer1 scientists @VolgaMSaini @C_CahillTCD & @oner_ez showcasing their longitudinal data on #CTCs in early stage #lungcancer at #ACTC25 Thanks to @hea_irl for supporting this important research #NSRPproject @CancerInstIRE @TCDTMI @stjamesdublin #lcsm

kathygately1's tweet image. Congrats to our @CluB_Cancer1 scientists @VolgaMSaini @C_CahillTCD & @oner_ez showcasing their longitudinal data on #CTCs in early stage #lungcancer at #ACTC25 Thanks to @hea_irl for supporting this important research #NSRPproject @CancerInstIRE @TCDTMI @stjamesdublin #lcsm
kathygately1's tweet image. Congrats to our @CluB_Cancer1 scientists @VolgaMSaini @C_CahillTCD & @oner_ez showcasing their longitudinal data on #CTCs in early stage #lungcancer at #ACTC25 Thanks to @hea_irl for supporting this important research #NSRPproject @CancerInstIRE @TCDTMI @stjamesdublin #lcsm
kathygately1's tweet image. Congrats to our @CluB_Cancer1 scientists @VolgaMSaini @C_CahillTCD & @oner_ez showcasing their longitudinal data on #CTCs in early stage #lungcancer at #ACTC25 Thanks to @hea_irl for supporting this important research #NSRPproject @CancerInstIRE @TCDTMI @stjamesdublin #lcsm

Congratulations to the 174 business development officers and specialists in 18 countries who successfully upgraded their skills to assist #MSMEs better!🎉🙌 Photo: @BYBT's Cardelle Fergusson w/ CDB's Michel Thomas. Details ➡️ ow.ly/ZUfq50PCZlh #caribdev #CTCS

Caribank's tweet image. Congratulations to the 174  business development officers and specialists in 18 countries who successfully upgraded their skills to assist #MSMEs better!🎉🙌

Photo: @BYBT's Cardelle Fergusson w/ CDB's Michel Thomas.

Details ➡️ ow.ly/ZUfq50PCZlh

#caribdev #CTCS

✅N-of-1 Precision Medicine: this story is very dear to my heart. Liquid biopsies➡️saving lives. We stumbled on HER2 in refractory liver cancer (HCC not cholangiocarcinoma). #CTCs🔴🟠🟡 not just #ctDNA🧬. AFP>200,000📉900 now. @OncoAlert Free Full text: sciencedirect.com/science/articl…

pashtoonkasi's tweet image. ✅N-of-1 Precision Medicine: this story is very dear to my heart.

Liquid biopsies➡️saving lives.
We stumbled on HER2 in refractory liver cancer (HCC not cholangiocarcinoma).

#CTCs🔴🟠🟡 not just #ctDNA🧬.
AFP>200,000📉900 now.

@OncoAlert
Free Full text: sciencedirect.com/science/articl…

👇🏾Isn’t this amazing? We are talking about Circulating Tumor Cells➖#CTCs🔵🟣🟡in blood🩸of patients with #Cancer now in 2023, whereas the 1st description of this was published in📰1️⃣8️⃣6️⃣9️⃣! Yes! 1869! Also, love the narrative: “I showed it to Prof👩‍🏫 X & 👨‍🏫 Z, & they agree.”😊

pashtoonkasi's tweet image. 👇🏾Isn’t this amazing?

We are talking about Circulating Tumor Cells➖#CTCs🔵🟣🟡in blood🩸of patients with #Cancer now in 2023, whereas the 1st description of this was published in📰1️⃣8️⃣6️⃣9️⃣!

Yes! 1869!

Also, love the narrative: “I showed it to Prof👩‍🏫 X & 👨‍🏫 Z, & they agree.”😊

Gunjan Tripathi at @vertexinc explores the history of #CTCs and their continued adoption by tax authorities around the world. thefintechtimes.com/vertex-reclaim…

thefintechtimes's tweet image. Gunjan Tripathi at @vertexinc explores the history of #CTCs and their continued adoption by tax authorities around the world. thefintechtimes.com/vertex-reclaim…

Circulating tumor cells (CTCs) are set to revolutionize solid tumor management. Their role, combined with circulating tumor DNA in multi-analyze assessments, holds great promise for advancing precision oncology and patient care. #CTCs #Oncology #LiquidBiopsy @isliquidbiopsy

DrYukselUrun's tweet image. Circulating tumor cells (CTCs) are set to revolutionize solid tumor management. Their role, combined with circulating tumor DNA in multi-analyze assessments, holds great promise for advancing precision oncology and patient care. #CTCs #Oncology #LiquidBiopsy @isliquidbiopsy

📢We're Excited to share the #SpecialIssue "Biomarkers in Liquid Biopsy: Circulating Tumor DNA (#ctDNA), Circulating Tumor Cells (#CTCs) and Exosomes" edited by Dr. George Zarkavelis (#University Hospital of Ioannina), now open for submissions! 👏 📌mdpi.com/journal/cancer…

Cancers_MDPI's tweet image. 📢We're Excited to share the #SpecialIssue "Biomarkers in Liquid Biopsy: Circulating Tumor DNA (#ctDNA), Circulating Tumor Cells (#CTCs) and Exosomes" edited by Dr. George Zarkavelis (#University Hospital of Ioannina), now open for submissions! 👏
📌mdpi.com/journal/cancer…

#GI23 @ASCO I’m delighted to share one of the largest👀at #CirculatingTumorCells in GI cancers. #CTCs🔵🟣: ➡️less talked about #LiquidBiopsies. We show feasibility & striking differences across tumor types. 💡#CRCSM >>> #PANCSM @OncoAlert @DrawImpacts meetings.asco.org/abstracts-pres…


Next-gen precision oncology in action. OncoIncytes: visualizing PD-L1 & HER2 expression in CTCs— real-time mutation tracking. From slides to survival. The future is cell-deep. #LiquidBiopsy #PrecisionOncology #CTCs #CancerResearch @OncoAlert @onecelldx @aravasudevan

DrYukselUrun's tweet image. Next-gen precision oncology in action.
OncoIncytes: visualizing PD-L1 & HER2 expression in CTCs—
real-time mutation tracking.
From slides to survival. 
The future is cell-deep.
#LiquidBiopsy #PrecisionOncology #CTCs #CancerResearch
@OncoAlert @onecelldx @aravasudevan

Senior Editor @commsmedicine Dr. Ben Abbott is delighted to be in Skiathos for the 6th #ACTC meeting. Please get in touch to discuss your work on #CTCs, #ctDNA & #LiquidBiopsy

CommsMedicine's tweet image. Senior Editor @commsmedicine Dr. Ben Abbott is delighted to be in Skiathos for the 6th #ACTC meeting. Please get in touch to discuss your work on #CTCs, #ctDNA & #LiquidBiopsy

CTCS provides respectful personal care services across the UK, supporting hygiene, comfort and dignity at home. Contact us: 📲0116 509 3300 📩[email protected] #PersonalCareUK #DignifiedCare #CTCS

ctcscare's tweet image. CTCS provides respectful personal care services across the UK, supporting hygiene, comfort and dignity at home.
Contact us:
📲0116 509 3300
📩adultcare@cometogether-cs.co.uk
#PersonalCareUK #DignifiedCare #CTCS

CTCS Supported Living and Home Care services help maintain independence while providing necessary support across the UK. Contact us: 📲0116 509 3300 📩[email protected] #IndependentLiving #SupportedLivingUK #CTCS

ctcscare's tweet image. CTCS Supported Living and Home Care services help maintain independence while providing necessary support across the UK.
Contact us:
📲0116 509 3300
📩adultcare@cometogether-cs.co.uk
#IndependentLiving #SupportedLivingUK #CTCS

It’s often the nights that bring the most worry. The silence, the “what ifs,” and that constant thought in the back of your mind. CTCS Live-in Care — peace of mind overnight. Contact us: 📲0116 509 3300 📩[email protected] #CTCS #LiveInCare #NightSupport


Delaying care decisions can lead to emergency situations. CTCS provides early intervention support across the UK. Contact us: 📲0116 509 3300 📩[email protected] #CarePlanning #HomeCareUK #CTCS

ctcscare's tweet image. Delaying care decisions can lead to emergency situations. CTCS provides early intervention support across the UK.
Contact us:
📲0116 509 3300
📩adultcare@cometogether-cs.co.uk
#CarePlanning #HomeCareUK #CTCS

Care needs often increase gradually before becoming urgent. CTCS provides proactive home care services across the UK. Contact us: 📲0116 509 3300 📩[email protected] #CareSupport #HomeCareUK #CTCS

ctcscare's tweet image. Care needs often increase gradually before becoming urgent. CTCS provides proactive home care services across the UK.
Contact us:
📲0116 509 3300
📩adultcare@cometogether-cs.co.uk
#CareSupport #HomeCareUK #CTCS

They used to cook every day. Now it’s biscuits and tea, and little by little, energy starts to fade. CTCS Home Care — proper daily support that brings balance back. Contact us: 📲0116 509 3300 📩[email protected] #CTCS #HomeCare #DailySupport #CareAtHome #UKCare


CTCS supports families across the UK with structured home care services that reduce pressure and improve daily living. Contact us: 📲0116 509 3300 📩[email protected] #FamilyCare #HomeCareUK #CTCS

ctcscare's tweet image. CTCS supports families across the UK with structured home care services that reduce pressure and improve daily living.
Contact us:
📲0116 509 3300
📩adultcare@cometogether-cs.co.uk
#FamilyCare #HomeCareUK #CTCS

Dr. Yuvraj Patil – Principal Scientist, Medical Devices, Actorius Innovations and Research, presents our investigational OncoMetastat® platform and the engineering behind its approach to circulating tumor cell (CTC) capture. #AACR2026 #CTCs #OncoMetastat #MedicalDevices


The worry doesn’t switch off at night. Checking your phone thinking “what if” That feeling doesn’t just go away but the right support can ease it. Contact us: 📲 0116 509 3300 📩[email protected] #CTCS #LiveInCare #PeaceOfMind #CareAtHome #UKCare #FamilySupport


Reduced social activity can impact mental and physical wellbeing. CTCS provides companionship and social support services across the UK. Contact us: 📲0116 509 3300 📩[email protected] #SocialSupportUK #LonelinessSupport #CTCS

ctcscare's tweet image. Reduced social activity can impact mental and physical wellbeing. CTCS provides companionship and social support services across the UK.
Contact us:
📲0116 509 3300
📩adultcare@cometogether-cs.co.uk
#SocialSupportUK #LonelinessSupport #CTCS

Choosing the right care provider impacts safety, wellbeing and independence. CTCS delivers structured, reliable care services across the UK. Contact us: 📲0116 509 3300 📩[email protected] #HomeCareUK #CareStandards #CTCS

ctcscare's tweet image. Choosing the right care provider impacts safety, wellbeing and independence. CTCS delivers structured, reliable care services across the UK.
Contact us:
📲0116 509 3300
📩adultcare@cometogether-cs.co.uk
#HomeCareUK #CareStandards #CTCS

Time-limited care visits can impact quality. CTCS prioritises attentive, structured care across the UK. Contact us: 📲0116 509 3300 📩[email protected] #CareQuality #HomeCareUK #CTCS

ctcscare's tweet image. Time-limited care visits can impact quality. CTCS prioritises attentive, structured care across the UK.
Contact us:
📲0116 509 3300
📩adultcare@cometogether-cs.co.uk
#CareQuality #HomeCareUK #CTCS

Post-discharge care is essential for recovery and reducing readmissions. CTCS provides structured home support across the UK after hospital stays. Contact us: 📲0116 509 3300 📩[email protected] #PostHospitalCare #HomeCareUK #CTCS

ctcscare's tweet image. Post-discharge care is essential for recovery and reducing readmissions. CTCS provides structured home support across the UK after hospital stays.
Contact us:
📲0116 509 3300
📩adultcare@cometogether-cs.co.uk
#PostHospitalCare #HomeCareUK #CTCS

Join us at AACR 2026. If you’re attending AACR, let’s connect and exchange ideas shaping the next phase of oncology innovation. 📍 Visit our Booth #3958 📅 Meet: actorius.com/resources/even… #AACR2026 #CTCs #OncologyResearch #Metastasis #OncoMetastat @AACR @Dr_JayantK @aravasudevan

Actorius_IR's tweet image. Join us at AACR 2026.

If you’re attending AACR, let’s connect and exchange ideas shaping the next phase of oncology innovation.

📍 Visit our Booth #3958
📅 Meet: actorius.com/resources/even…

#AACR2026 #CTCs #OncologyResearch #Metastasis #OncoMetastat
@AACR @Dr_JayantK @aravasudevan
Actorius_IR's tweet image. Join us at AACR 2026.

If you’re attending AACR, let’s connect and exchange ideas shaping the next phase of oncology innovation.

📍 Visit our Booth #3958
📅 Meet: actorius.com/resources/even…

#AACR2026 #CTCs #OncologyResearch #Metastasis #OncoMetastat
@AACR @Dr_JayantK @aravasudevan

Mobility decline is often gradual but increases fall risk. CTCS provides home care support across the UK to assist with safe movement and daily living. Contact us: 📲0116 509 3300 📩[email protected] #MobilitySupport #HomeCareUK #CTCS

ctcscare's tweet image. Mobility decline is often gradual but increases fall risk. CTCS provides home care support across the UK to assist with safe movement and daily living.
Contact us:
📲0116 509 3300
📩adultcare@cometogether-cs.co.uk
#MobilitySupport #HomeCareUK #CTCS

A nation of Christians, who are being told by their politicians and talking heads in prominent places of power, to stand down and not fight back against a horde of Islamist invaders seeking to decimate their numbers, will be culled as quickly as lambs to the slaughter... #CTCS


CTCS provides high-quality home care services across the UK, focusing on consistency, attention and person-centred support. Contact us: 📲0116 509 3300 📩[email protected] #HomeCareUK #CareStandards #CTCS

ctcscare's tweet image. CTCS provides high-quality home care services across the UK, focusing on consistency, attention and person-centred support.

Contact us:
📲0116 509 3300
📩adultcare@cometogether-cs.co.uk

#HomeCareUK #CareStandards #CTCS

They’re still managing… technically. But everything takes a little longer, a little more effort — and carries a little more risk. Contact us: 📲0116 509 3300 📩[email protected] #CTCS #HomeCare #EarlySupport #CareAtHome #UKCare #SupportMatters #PreventionMatters


Social isolation remains a major issue across the UK. CTCS provides companionship and social support services to improve wellbeing and reduce loneliness. Contact us: 📲0116 509 3300 📩[email protected] #SocialSupportUK #LonelinessSupport #CTCS #CompanionshipCare

ctcscare's tweet image. Social isolation remains a major issue across the UK. CTCS provides companionship and social support services to improve wellbeing and reduce loneliness.
Contact us:
📲0116 509 3300
📩adultcare@cometogether-cs.co.uk
#SocialSupportUK #LonelinessSupport #CTCS #CompanionshipCare

Effective dementia care focuses on calm communication and routine rather than correction. CTCS provides structured dementia support across the UK. Contact us: 📲0116 509 3300 📩[email protected] #DementiaSupportUK #MemoryCare #CTCS

ctcscare's tweet image. Effective dementia care focuses on calm communication and routine rather than correction. CTCS provides structured dementia support across the UK.
Contact us:
📲0116 509 3300
📩adultcare@cometogether-cs.co.uk
#DementiaSupportUK #MemoryCare #CTCS

Recent advances in droplet-based microfluidics in liquid biopsy for cancer diagnosis. Strengths, drawbacks, challenges and future perspectives. #CTCs #ctDNA #miRNA Circulating tumor #exosomes 🔻 doi.org/10.1002/dro2.92

CrozrX's tweet image. Recent advances in droplet-based microfluidics in liquid biopsy for cancer diagnosis. Strengths, drawbacks, challenges and future perspectives.
#CTCs #ctDNA #miRNA Circulating tumor #exosomes
🔻
doi.org/10.1002/dro2.92
CrozrX's tweet image. Recent advances in droplet-based microfluidics in liquid biopsy for cancer diagnosis. Strengths, drawbacks, challenges and future perspectives.
#CTCs #ctDNA #miRNA Circulating tumor #exosomes
🔻
doi.org/10.1002/dro2.92
CrozrX's tweet image. Recent advances in droplet-based microfluidics in liquid biopsy for cancer diagnosis. Strengths, drawbacks, challenges and future perspectives.
#CTCs #ctDNA #miRNA Circulating tumor #exosomes
🔻
doi.org/10.1002/dro2.92
CrozrX's tweet image. Recent advances in droplet-based microfluidics in liquid biopsy for cancer diagnosis. Strengths, drawbacks, challenges and future perspectives.
#CTCs #ctDNA #miRNA Circulating tumor #exosomes
🔻
doi.org/10.1002/dro2.92

Recent Developments in Inertial and Centrifugal Microfluidic Systems along with the Involved Forces for Cancer Cell Separation: A Review mdpi.com/1424-8220/23/1… #CTCs #CancerMetastasis #CellEnrichment #CancerDiagnosis #LOC #LOCD

Sensors_MDPI's tweet image. Recent Developments in Inertial and Centrifugal Microfluidic Systems  along with the Involved Forces for Cancer Cell Separation: A Review
mdpi.com/1424-8220/23/1…
#CTCs #CancerMetastasis #CellEnrichment #CancerDiagnosis #LOC #LOCD

Timely #AACR24 with the 1st approval of an agnostic ADC for HER2-positive cancers. ?debate on criteria. My 2 cents: the true HER2➕➕➕ are hard to miss🔬. 💡➕it’ll be corroborated by ERBB2 🧬 amplification on other tests #ctDNA #CTCs. Approval🔑➡️access.👇🏾is HCC. @OncoAlert

pashtoonkasi's tweet image. Timely #AACR24 with the 1st approval of an agnostic ADC for HER2-positive cancers.

?debate on criteria.

My 2 cents: the true HER2➕➕➕ are hard to miss🔬.

💡➕it’ll be corroborated by ERBB2 🧬 amplification on other tests #ctDNA #CTCs.

Approval🔑➡️access.👇🏾is HCC. @OncoAlert

✅N-of-1 Precision Medicine: this story is very dear to my heart. Liquid biopsies➡️saving lives. We stumbled on HER2 in refractory liver cancer (HCC not cholangiocarcinoma). #CTCs🔴🟠🟡 not just #ctDNA🧬. AFP>200,000📉900 now. @OncoAlert Free Full text: sciencedirect.com/science/articl…

pashtoonkasi's tweet image. ✅N-of-1 Precision Medicine: this story is very dear to my heart.

Liquid biopsies➡️saving lives.
We stumbled on HER2 in refractory liver cancer (HCC not cholangiocarcinoma).

#CTCs🔴🟠🟡 not just #ctDNA🧬.
AFP>200,000📉900 now.

@OncoAlert
Free Full text: sciencedirect.com/science/articl…


Liquid biopsy plenary from Dr. @AlixPanabieres at #Targets23. A global leader in #CTCs - shows what we can learn about drug resistance from CTC clones, such as her a eminal work on culturing CTCs. More complexity than ctDNA. Ready for more interventional studies in this space!

StephenVLiu's tweet image. Liquid biopsy plenary from Dr. @AlixPanabieres at #Targets23. A global leader in #CTCs - shows what we can learn about drug resistance from CTC clones, such as her a eminal work on culturing CTCs. More complexity than ctDNA. Ready for more interventional studies in this space!

✅N-of-1 Precision Medicine: this story is very dear to my heart. Liquid biopsies➡️saving lives. We stumbled on HER2 in refractory liver cancer (HCC not cholangiocarcinoma). #CTCs🔴🟠🟡 not just #ctDNA🧬. AFP>200,000📉900 now. @OncoAlert Free Full text: sciencedirect.com/science/articl…

pashtoonkasi's tweet image. ✅N-of-1 Precision Medicine: this story is very dear to my heart.

Liquid biopsies➡️saving lives.
We stumbled on HER2 in refractory liver cancer (HCC not cholangiocarcinoma).

#CTCs🔴🟠🟡 not just #ctDNA🧬.
AFP>200,000📉900 now.

@OncoAlert
Free Full text: sciencedirect.com/science/articl…

👇🏾Isn’t this amazing? We are talking about Circulating Tumor Cells➖#CTCs🔵🟣🟡in blood🩸of patients with #Cancer now in 2023, whereas the 1st description of this was published in📰1️⃣8️⃣6️⃣9️⃣! Yes! 1869! Also, love the narrative: “I showed it to Prof👩‍🏫 X & 👨‍🏫 Z, & they agree.”😊

pashtoonkasi's tweet image. 👇🏾Isn’t this amazing?

We are talking about Circulating Tumor Cells➖#CTCs🔵🟣🟡in blood🩸of patients with #Cancer now in 2023, whereas the 1st description of this was published in📰1️⃣8️⃣6️⃣9️⃣!

Yes! 1869!

Also, love the narrative: “I showed it to Prof👩‍🏫 X & 👨‍🏫 Z, & they agree.”😊

Key 🔑 for growing organoids from⬅️🟣🔵🔴#CTCs is picking the: ✔️right time ✔️right biology ✔️right platform ✔️efficient communication ✔️timely processing ✅great team 🤝🙌🏽 @ReduzziCarol @CtcLaboratory #ColorectalCancer #CRCSM #BCSM #ISLB24 @isliquidbiopsy #LiquidBiopsies

pashtoonkasi's tweet image. Key 🔑 for 
growing organoids from⬅️🟣🔵🔴#CTCs is picking the:
✔️right time
✔️right biology
✔️right platform
✔️efficient communication
✔️timely processing
✅great team 🤝🙌🏽

@ReduzziCarol @CtcLaboratory 

#ColorectalCancer #CRCSM #BCSM 
 #ISLB24 @isliquidbiopsy #LiquidBiopsies

MicroOrganoSphere (MOS): A new approach for growing circulating tumor cell (CTC)-derived organoids. Promising results in BC & CRC samples, though challenges in growth phase remain. 🩸 Unlocking CTC potential for precision oncology! #LiquidBiopsy #Oncology #ISLB24

DrYukselUrun's tweet image. MicroOrganoSphere (MOS): A new approach for growing circulating tumor cell (CTC)-derived organoids. Promising results in BC & CRC samples, though challenges in growth phase remain.

🩸 Unlocking CTC potential for precision oncology!

#LiquidBiopsy #Oncology #ISLB24


Mesenchymal (vimentin+) circulating tumor cells (#CTCs) may be progostic for progression in ALK+ #NSCLC. Great to see more non-invasive tests for progression. Collaboration between @NagrathSunitha Dr. Yuru Chen & Dr. Angel Qin @UMRogelCancer #AACR25 @ALKPositiveinc

LUNGevity's tweet image. Mesenchymal (vimentin+) circulating tumor cells (#CTCs) may be progostic for progression in ALK+ #NSCLC. Great to see more non-invasive tests for progression. Collaboration between @NagrathSunitha Dr. Yuru Chen & Dr. Angel Qin @UMRogelCancer #AACR25 @ALKPositiveinc
LUNGevity's tweet image. Mesenchymal (vimentin+) circulating tumor cells (#CTCs) may be progostic for progression in ALK+ #NSCLC. Great to see more non-invasive tests for progression. Collaboration between @NagrathSunitha Dr. Yuru Chen & Dr. Angel Qin @UMRogelCancer #AACR25 @ALKPositiveinc
LUNGevity's tweet image. Mesenchymal (vimentin+) circulating tumor cells (#CTCs) may be progostic for progression in ALK+ #NSCLC. Great to see more non-invasive tests for progression. Collaboration between @NagrathSunitha Dr. Yuru Chen & Dr. Angel Qin @UMRogelCancer #AACR25 @ALKPositiveinc

📢We're Excited to share the #SpecialIssue "Biomarkers in Liquid Biopsy: Circulating Tumor DNA (#ctDNA), Circulating Tumor Cells (#CTCs) and Exosomes" edited by Dr. George Zarkavelis (#University Hospital of Ioannina), now open for submissions! 👏 📌mdpi.com/journal/cancer…

Cancers_MDPI's tweet image. 📢We're Excited to share the #SpecialIssue "Biomarkers in Liquid Biopsy: Circulating Tumor DNA (#ctDNA), Circulating Tumor Cells (#CTCs) and Exosomes" edited by Dr. George Zarkavelis (#University Hospital of Ioannina), now open for submissions! 👏
📌mdpi.com/journal/cancer…

Circulating tumor cells (CTCs) are set to revolutionize solid tumor management. Their role, combined with circulating tumor DNA in multi-analyze assessments, holds great promise for advancing precision oncology and patient care. #CTCs #Oncology #LiquidBiopsy @isliquidbiopsy

DrYukselUrun's tweet image. Circulating tumor cells (CTCs) are set to revolutionize solid tumor management. Their role, combined with circulating tumor DNA in multi-analyze assessments, holds great promise for advancing precision oncology and patient care. #CTCs #Oncology #LiquidBiopsy @isliquidbiopsy

🌟Calling for Papers🌟 📚 New #SpecialIssue: Circulating Tumor Cells (CTCs) for Cancer Diagnosis and Prognosis 👨‍🔬Guest Editor: Dr. Athina N. Markou 🔗Find Out More: mdpi.com/journal/cancer… #CTCs #liquid biopsy #metastasis #biomarkers

Cancers_MDPI's tweet image. 🌟Calling for Papers🌟
📚 New #SpecialIssue: Circulating Tumor Cells (CTCs) for Cancer Diagnosis and Prognosis
👨‍🔬Guest Editor: Dr. Athina N. Markou
🔗Find Out More: mdpi.com/journal/cancer…

#CTCs #liquid biopsy #metastasis #biomarkers

Next-gen precision oncology in action. OncoIncytes: visualizing PD-L1 & HER2 expression in CTCs— real-time mutation tracking. From slides to survival. The future is cell-deep. #LiquidBiopsy #PrecisionOncology #CTCs #CancerResearch @OncoAlert @onecelldx @aravasudevan

DrYukselUrun's tweet image. Next-gen precision oncology in action.
OncoIncytes: visualizing PD-L1 & HER2 expression in CTCs—
real-time mutation tracking.
From slides to survival. 
The future is cell-deep.
#LiquidBiopsy #PrecisionOncology #CTCs #CancerResearch
@OncoAlert @onecelldx @aravasudevan

Delighted to have contributed to this book📕on Transplant Oncology. Edited by: @MaenAbdelrahim Foreword: @JimAllisonPhD 📝My chapter focuses on #LiquidBiopsies #CTCs, 🟣🟠 #ctDNA🩸🧬and beyond💡. Out now➡️Amazon/Elsevier. 📌a.co/d/bOQu50R @OncoAlert @DrawImpacts

pashtoonkasi's tweet image. Delighted to have contributed to this book📕on Transplant Oncology. 

Edited by: @MaenAbdelrahim
Foreword: @JimAllisonPhD

📝My chapter focuses on #LiquidBiopsies #CTCs, 🟣🟠 #ctDNA🩸🧬and beyond💡.

Out now➡️Amazon/Elsevier. 
📌a.co/d/bOQu50R

@OncoAlert @DrawImpacts
pashtoonkasi's tweet image. Delighted to have contributed to this book📕on Transplant Oncology. 

Edited by: @MaenAbdelrahim
Foreword: @JimAllisonPhD

📝My chapter focuses on #LiquidBiopsies #CTCs, 🟣🟠 #ctDNA🩸🧬and beyond💡.

Out now➡️Amazon/Elsevier. 
📌a.co/d/bOQu50R

@OncoAlert @DrawImpacts
pashtoonkasi's tweet image. Delighted to have contributed to this book📕on Transplant Oncology. 

Edited by: @MaenAbdelrahim
Foreword: @JimAllisonPhD

📝My chapter focuses on #LiquidBiopsies #CTCs, 🟣🟠 #ctDNA🩸🧬and beyond💡.

Out now➡️Amazon/Elsevier. 
📌a.co/d/bOQu50R

@OncoAlert @DrawImpacts

#Aritcle A novel spiral #microfluidic chip with pillars enriches #CTCs by inertial hydrodynamic forces at high flow rate resulting in WBC depletion rate >90% and CTC recovery rate between 62%-83%. mdpi.com/2079-6374/13/1…

Biosensors_MDPI's tweet image. #Aritcle
A novel spiral #microfluidic chip with pillars enriches #CTCs by inertial hydrodynamic forces at high flow rate resulting in WBC depletion rate >90% and CTC recovery rate between 62%-83%.
mdpi.com/2079-6374/13/1…

Circulating tumor cells (#CTCs) dynamics after CDK4/6i for hormone receptor positive (HR+) #metastaticbreastcancer (MBC): a biomarker analysis of the PACE randomized phase II study @LGerratana @MCristofanill @CroAviano @WCM_MeyerCancer @DFCI_BreastOnc

CtcLaboratory's tweet image. Circulating tumor cells (#CTCs) dynamics after CDK4/6i for hormone receptor positive (HR+) #metastaticbreastcancer (MBC): a biomarker analysis of the PACE randomized phase II study @LGerratana @MCristofanill @CroAviano @WCM_MeyerCancer @DFCI_BreastOnc
CtcLaboratory's tweet image. Circulating tumor cells (#CTCs) dynamics after CDK4/6i for hormone receptor positive (HR+) #metastaticbreastcancer (MBC): a biomarker analysis of the PACE randomized phase II study @LGerratana @MCristofanill @CroAviano @WCM_MeyerCancer @DFCI_BreastOnc
CtcLaboratory's tweet image. Circulating tumor cells (#CTCs) dynamics after CDK4/6i for hormone receptor positive (HR+) #metastaticbreastcancer (MBC): a biomarker analysis of the PACE randomized phase II study @LGerratana @MCristofanill @CroAviano @WCM_MeyerCancer @DFCI_BreastOnc

ICYMI: Surface Marker Identification to Capture Live Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer. doi.org/10.1158/2767-9… #CTCs #TNBC #OpenAccess

CRC_AACR's tweet image. ICYMI: Surface Marker Identification to Capture Live Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer. doi.org/10.1158/2767-9…
#CTCs #TNBC #OpenAccess

Congratulations to the 174 business development officers and specialists in 18 countries who successfully upgraded their skills to assist #MSMEs better!🎉🙌 Photo: @BYBT's Cardelle Fergusson w/ CDB's Michel Thomas. Details ➡️ ow.ly/ZUfq50PCZlh #caribdev #CTCS

Caribank's tweet image. Congratulations to the 174  business development officers and specialists in 18 countries who successfully upgraded their skills to assist #MSMEs better!🎉🙌

Photo: @BYBT's Cardelle Fergusson w/ CDB's Michel Thomas.

Details ➡️ ow.ly/ZUfq50PCZlh

#caribdev #CTCS

Loading...

Something went wrong.


Something went wrong.